AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2020

Aug 7, 2020

30016_dirs_2020-08-07_648373f0-53bf-498c-a12d-a71f830c94d1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2020-08-05

Reporting Person: MCKEON BRIAN P (EVP, CFO & Treasurer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-05	Common Stock	M	193	—	Acquired	49693	Direct
2020-08-05	Common Stock	F	97	$395.71	Disposed	49596	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-05	Restricted Stock Unit	$	M	193	Disposed		Common Stock (193)	Direct

Footnotes

F1: Includes a total of 43 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2020 and June 30, 2020.

F2: Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning August 5, 2020.

F3: Not applicable.